Response to Antiepileptic Drug Therapy: Winners and Losers
Open Access
- 14 December 2005
- Vol. 46 (s10) , 31-32
- https://doi.org/10.1111/j.1528-1167.2005.00355.x
Abstract
Summary: Recent evidence suggests that the vast majority of people with epilepsy will respond to their first or second treatment regimen or will be refractory de novo. Two patients with symptomatic epilepsy secondary to underlying cortical dysplasias are presented to illustrate these different scenarios. Clinical observations can provide insights to the processes underlying pharmacoresistance.Keywords
This publication has 5 references indexed in Scilit:
- Potential Role of Drug Transporters in the Pathogenesis of Medically Intractable EpilepsyEpilepsia, 2005
- Mechanisms of antiepileptic drug resistanceCurrent Opinion in Neurology, 2003
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981